Chemotherapy‐induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care.

MLA

Merjaneh, Nawal, et al. “Chemotherapy‐induced Thrombocytopenia in Ewing Sarcoma: Implications and Potential for Romiplostim Supportive Care.” Pediatric Blood & Cancer, vol. 69, no. 7, July 2022, pp. 1–6. EBSCOhost, https://doi.org/10.1002/pbc.29548.

APA

Merjaneh, N., Young, J., Mangoli, A., Olsen, M., Setty, B., Lane, A., Nagarajan, R., Pressey, J. G., & Turpin, B. (2022). Chemotherapy‐induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care. Pediatric Blood & Cancer, 69(7), 1–6. https://doi.org/10.1002/pbc.29548

Chicago

Merjaneh, Nawal, Jennifer Young, Avani Mangoli, Mallery Olsen, Bhuvana Setty, Adam Lane, Rajaram Nagarajan, Joseph G. Pressey, and Brian Turpin. 2022. “Chemotherapy‐induced Thrombocytopenia in Ewing Sarcoma: Implications and Potential for Romiplostim Supportive Care.” Pediatric Blood & Cancer 69 (7): 1–6. doi:10.1002/pbc.29548.